ArticleRevue francaise d'allergologie (2009)2022

The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment.

E Atayik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.